Search Results 1821-1830 of 17011 for monoclonal antibody
Prior exposure to any anti-PD-1 or anti-PD-L1 antibody or anti CTLA4; Brain metastases or spinal cord compression unless asymptomatic, treated and stable ...
The purpose of this research is to determine if experimental treatment with AZD5863, a T cell-engaging bispecific antibody that targets Claudin 18.2 (CLDN18.
... antibodies) treatment, CPI-naïve hepatocellular carcinoma (HCC), and treatment-naïve endometrioid endometrial cancer. Methylation and Chromatin ...
Participation eligibility · Adults aged 18 years or older. · Confirmed diagnosis of urothelial cancer. · Scheduled to initiate antibodydrug conjugate (ADC) therapy ...
Transplant Immunology Program. Sections. Overview · Faculty and staff; Research Research. Antibody Barriers Project · Long-Term Outcomes Project · Consortium ...
Waldenstrom's macroglobulinemia; POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome; Plasma cell leukemia ...
Patients have plasma cell leukemia, Waldenström macroglobulinemia, POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin ...
Subjects taking the following medications: Immunosuppressive treatment with systemic azathioprine, Cyclosporine, antibodies or cytostatics, other ...
It's coated with antibodies that target the HER2 receptor, a common molecule found on 40 percent of breast cancers. It's also coated with molecules that ...
History or presence of hepatitis B (surface antigen positivity), active hepatitis C or human immunodeficiency virus (HIV) antibody; Active infection within ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.